Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer
PROLONG 研究的治疗原理和设计:帕博利珠单抗作为老年非小细胞肺癌患者一线治疗的安全性和有效性
期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd.2019.12.46
Masuda, Takeshi; Fujitaka, Kazunori; Ishikawa, Nobuhisa; Nakano, Kikuo; Yamasaki, Masahiro; Kitaguchi, Souichi; Masuda, Ken; Yamaguchi, Kakuhiro; Sakamoto, Shinjiro; Horimasu, Yasushi; Kawase, Shigeo; Miyamoto, Shintaro; Nakashima, Taku; Iwamoto, Hiroshi; Shiota, Naoki; Senoo, Tadashi; Awaya, Yoshikazu; Kondo, Tomohiro; Yoshida, Takashi; Hamada, Hironobu; Murakami, Isao; Hattori, Noboru